Evommune, Inc.

EVMNNYSE • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
19.92 USD
↘ 0.77 (3.72%)AT CLOSE (11:59 AM EDT)
19.79
↘ 0.13 (0.63%)
POST MARKET (AS OF 08:05 PM EDT)
Post Market
AS OF 08:05 PM EDT
19.79
↘ 0.13 (0.63%)
🔴Market: CLOSED
Open?$20.52
High?$21.23
Low?$19.60
Prev. Close?$20.69
Volume?417.4K
Avg. Volume?399.6K
VWAP?$20.21
Rel. Volume?1.04x
Bid / Ask
Bid?$19.83 × 100
Ask?$22.00 × 100
Spread?$2.17
Midpoint?$20.92
Valuation & Ratios
Market Cap?717.5M
Shares Out?36.0M
Float?10.0M
Float %?31.9%
P/E Ratio?N/A
P/B Ratio?2.36
EPS?-$2.14
Dividend?0.00%
Ex-Dividend?N/A

Evommune, Inc. (EVMN) trades at $19.92 per share. Technical indicators currently signal "Strong Sell". Key drivers include negative Return on Equity. EVMN is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Themes
Biotech - Drug Development›Immunology & Autoimmune
Employees
48
Market Cap
717.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.evommune.com
Listed
2025-11-06
Address
1891 PAGE MILL RD
PALO ALTO, CA
Phone: (650) 223-7745
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestSqueeze Risk
Short % of Float?30.84%Squeeze Risk
Short Interest?3.1M
Days to Cover?7.2
Free Float10.0M
Avg Daily Volume433.4K
Settlement Date2026-05-15
Financial Health
Current Ratio?20.36Strong
Quick Ratio?20.36Strong
Cash Ratio?4.56Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
67
2.36CHEAP▾
P/S?
Peers
100
S&P
3
55.19HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.3CHEAP▾
EV/Sales?
Peers
100
S&P
3
51.52HIGH▾
Returns & Efficiency
ROE?
S&P
7
-25.3%WEAK▾
ROA?
S&P
3
-23.9%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$669.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist